PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER

Ph.D

Saved in:

Bibliographic Details
Main Author:	JIANG XIA
Other Authors:	PHYSIOLOGY
Format:	Theses and Dissertations
Language:	English
Published:	2014
Subjects:	EPIGENETIC, ANTICANCER, AML, METASTATIC, BREAST, CANCER
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/53782
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-53782
record_format	dspace
spelling	sg-nus-scholar.10635-537822016-05-11T19:44:05Z PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER JIANG XIA PHYSIOLOGY YU QIANG HOOI SHING CHUAN EPIGENETIC, ANTICANCER, AML, METASTATIC, BREAST, CANCER Ph.D DOCTOR OF PHILOSOPHY 2014-06-10T18:00:20Z 2014-06-10T18:00:20Z 2013-10-17 Thesis JIANG XIA (2013-10-17). PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER. ScholarBank@NUS Repository. http://scholarbank.nus.edu.sg/handle/10635/53782 NOT_IN_WOS en
institution	National University of Singapore
building	NUS Library
country	Singapore
collection	ScholarBank@NUS
language	English
topic	EPIGENETIC, ANTICANCER, AML, METASTATIC, BREAST, CANCER
spellingShingle	EPIGENETIC, ANTICANCER, AML, METASTATIC, BREAST, CANCER JIANG XIA PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER
description	Ph.D
author2	PHYSIOLOGY
author_facet	PHYSIOLOGY JIANG XIA
format	Theses and Dissertations
author	JIANG XIA
author_sort	JIANG XIA
title	PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER
title_short	PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER
title_full	PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER
title_fullStr	PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER
title_full_unstemmed	PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER
title_sort	preclinical investigation of 3-deazaneplanocin a (dznep) analog 1-3 as a new epigenetic anticancer agent in human acute myeloid leukemia (aml) and metastatic breast cancer
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/53782
_version_	1681084200842690560

PRECLINICAL INVESTIGATION OF 3-DEAZANEPLANOCIN A (DZNEP) ANALOG 1-3 AS A NEW EPIGENETIC ANTICANCER AGENT IN HUMAN ACUTE MYELOID LEUKEMIA (AML) AND METASTATIC BREAST CANCER

Similar Items